The rapid rollout of Israel’s vaccination program has led to considerable international interest. In this brief commentary we consider how the criteria for vaccination priority groups differ between Israel and selected European countries. We argue that following the Israeli approach of using broad criteria for prioritization— i.e. having fewer groups and a lower age threshold— could have several beneficial effects, including more manageable logistics and fewer roll out delays, as well as potentially reducing pressure on hospitals. With an increasing supply of vaccines becoming available rapidly in much of Europe, countries could consider following the approach of Israel and adopting broader priority criteria going forward
Once a safe COVID-19 vaccine will become available, there will not be enough supply of it to vaccina...
BACKGROUND: Countries in the World Health Organization (WHO) European Region differ in terms of the ...
BACKGROUND: Countries in the World Health Organization (WHO) European Region differ in terms of the ...
The rapid rollout of Israel’s vaccination program has led to considerable international interest. In...
With the limited initial availability of COVID-19 vaccines in the first months of 2021, decision mak...
With the limited initial availability of COVID-19 vaccines in the first months of 2021, decision-mak...
Abstract As of March 31, 2021, Israel had administered 116 doses of vaccine for COVID-19 per 100 pop...
Background: Although there is rapid progress in vaccine research regarding influenza pandemic vac...
ABSTRACTBackgroundHow best to prioritise COVID-19 vaccination within and between countries has been ...
With the limited initial availability of COVID-19 vaccines in the first months of 2021, decision-mak...
BACKGROUND: How best to prioritise COVID-19 vaccination within and between countries has been a publ...
The development of COVID-19 vaccines is occurring at a rapid pace, with the potential for a vaccine ...
Once a safe COVID-19 vaccine will become available, there will not be enough supply of it to vaccina...
BACKGROUND: Countries in the World Health Organization (WHO) European Region differ in terms of the ...
BACKGROUND: Countries in the World Health Organization (WHO) European Region differ in terms of the ...
The rapid rollout of Israel’s vaccination program has led to considerable international interest. In...
With the limited initial availability of COVID-19 vaccines in the first months of 2021, decision mak...
With the limited initial availability of COVID-19 vaccines in the first months of 2021, decision-mak...
Abstract As of March 31, 2021, Israel had administered 116 doses of vaccine for COVID-19 per 100 pop...
Background: Although there is rapid progress in vaccine research regarding influenza pandemic vac...
ABSTRACTBackgroundHow best to prioritise COVID-19 vaccination within and between countries has been ...
With the limited initial availability of COVID-19 vaccines in the first months of 2021, decision-mak...
BACKGROUND: How best to prioritise COVID-19 vaccination within and between countries has been a publ...
The development of COVID-19 vaccines is occurring at a rapid pace, with the potential for a vaccine ...
Once a safe COVID-19 vaccine will become available, there will not be enough supply of it to vaccina...
BACKGROUND: Countries in the World Health Organization (WHO) European Region differ in terms of the ...
BACKGROUND: Countries in the World Health Organization (WHO) European Region differ in terms of the ...